Abstract:Introduction: Good syndrome (GS) is a rare adult-onset immunodeficiency first described in 1954. It is characterized by the coexistence of a thymoma and hypogammaglobulinemia, associated with an increased susceptibility to infections and autoimmunity. The classification and management of GS has been long hampered by the lack of data about the underlying immune alterations, a controversy existing on whether it is a unique diagnostic entity vs. a subtype of Common Variable Immune Deficiency (CVID). Methods: Here, we used high-sensitive flow cytometry to investigate the distribution of up to 70 different immune cell populations in blood of GS patients (n=9) compared to age-matched CVID patients (n=55) and healthy donors (n=61). Results: All 9 GS patients displayed reduced B-cell counts -down to undetectable levels (<0.1 cells/μL) in 8/9 cases-, together with decreased numbers of total CD4+ T-cells, NK-cells, neutrophils, and basophils vs. age-matched healthy donors. In contrast, they showed expanded TCRγδ+ T-cells (p ≤ 0.05). Except for a deeper B-cell defect, the pattern of immune cell alteration in blood was similar in GS and (age-matched) CVID patients. In depth analysis of CD4+ T-cells revealed significantly decreased blood counts of naïve, central memory (CM) and transitional memory (TM) TCD4+ cells and their functional compartments of T follicular helper (TFH), regulatory T cells (Tregs), T helper (Th)2, Th17, Th22, Th1/Th17 and Th1/Th2 cells. In addition, GS patients also showed decreased NK-cell, neutrophil, basophil, classical monocyte and of both CD1c+ and CD141+ myeloid dendritic cell counts in blood, in parallel to an expansion of total and terminal effector TCRγδ+ T-cells. Interestingly, those GS patients who developed hypogammaglobulinemia several years after the thymoma presented with an immunological and clinical phenotype which more closely resembled a combined immune humoral and cellular defect, with poorer response to immunoglobulin replacement therapy, as compared to those in whom the thymoma and hypogammaglobulinemia were simultaneously detected. Discussion: Our findings provide a more accurate definition of the immune cell defects of GS patients and contribute to a better discrimination among GS patients between those with a pure B-cell defect vs. those suffering from a combined immunodeficiency with important consequences on the diagnosis and management of the disease.

Griscelli Syndrome Type 2: Comprehensive Analysis of 149 New and Previously Described Patients with RAB27A Deficiency

Griscelli syndrome: a diagnostic challenge of a rare disease: a case report

Silvery Gray Hair Syndrome With Hemophagocytic Lymphohistiocytosis: A Case Report

First Co-Occurrence of Griscelli Syndrome Type 2 and Neurofibromatosis Type 1

Identification of a Novel MLPH Missense Mutation in a Chinese Griscelli Syndrome 3 Patient

Correction of Griscelli Syndrome Type 2 causing mutations in the RAB27A gene with CRISPR/Cas9

GATA2 deficiency and hemophagocytic lymphohistiocytosis (HLH): a systematic review of reported cases

Early diagnosis of immunodeficient patients with partial albinism: The role of hair study and peripheral blood smear

From variant of uncertain significance to likely pathogenic in two siblings with atypical RAG2 Deficiency: a case report and review of the literature

Hermansky-Pudlak Syndrome Type 2: A Case Report on an Ultra-Rare Disorder

GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects

Immunologic Heterogeneity in 2 Cartilage-Hair Hypoplasia Patients With a Distinct Clinical Course

Hereditary spastic paraparesis type 46 (SPG46): new GBA2 variants in a large Italian case series and review of the literature

Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity

In-depth blood immune profiling of Good syndrome patients

Clinical and functional spectrum of RAC2-related immunodeficiency

Good syndrome and cytomegalovirus retinitis: A literature review.

Changes in redox and endoplasmic reticulum homeostasis are related to congenital generalized lipodystrophy type 2

H syndrome treated with Tocilizumab: two case reports and literature review

Case Report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibition

RASGRP1 Mutation in Autoimmune Lymphoproliferative Syndrome-Like Disease